High-performance liquid chromatography quantitation of plasma lamotrigine concentrations: Application measuring trough concentrations in patients with epilepsy

Therapeutic Drug Monitoring

Volumn 19, Issue 6, 1997, Pages 688-693

  Sallustio, Benedetta C ^a   Morris, Raymond G ^a  

^a QUEEN ELIZABETH HOSPITAL   (Australia)

Author keywords

Drug interactions; HPLC; Lamotrigine; Therapeutic drug monitoring

Indexed keywords

ACETIC ACID ETHYL ESTER; ANTICONVULSIVE AGENT; BWA 725C; CARBAMAZEPINE; LAMOTRIGINE; METHANOL; PHENOBARBITAL; PHENYTOIN; REAGENT; SILICON DIOXIDE; UNCLASSIFIED DRUG; VALPROIC ACID;

ARTICLE; CONTROLLED STUDY; DRUG BLOOD LEVEL; DRUG METABOLISM; DRUG MONITORING; EPILEPSY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; ULTRAVIOLET IRRADIATION;

ANTICONVULSANTS; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; DRUG INTERACTIONS; DRUG MONITORING; EPILEPSY; HUMANS; REPRODUCIBILITY OF RESULTS; TRIAZINES;

EID: 0031454601     PISSN: 01634356     EISSN: None     Source Type: Journal    
DOI: 10.1097/00007691-199712000-00014     Document Type: Article

References (20)

1. Fitton A, Goa KL. Lamotrigine: an update of its pharmacology and therapeutic use in epilepsy. Drugs 1995;50:691-713.
2. Brodie MJ. Lamotrigine. Lancet 1992;339:1397-1400.
3. Rambeck B, Wolf B. Lamotrigine clinical pharmacokinetics. Clin Pharmacokinet 1993;25(6):433-43.
4. Storalek I, Blacklaw J, Forrest G, et al. Vigabatrin and lamotrigine in refractory epilepsy. J Neurol Neurosurg Psychiatry 1994;57: 921-4.
5. Yau MK, Lai AA, Womble GP, et al. Lamotrigine pharmacodynamics in adult patients: safety and efficacy [abstract]. Clin Pharmacol Ther 1994;55:160.
6. Matsuo F, Bergen D, Faught E, et al. Placebo-controlled study of the efficacy and safety of lamotrigine in patients with partial seizures. Neurology 1993;43:2284-91.
7. Schapel GJ, Beran RG, Vajda FJE, et al. Double-blind, placebo controlled, crossover study of lamotrigine in treatment resistant partial seizures. J Neural Neurosurg Psychiatry 1993;56:448-53.
8. Posner J, Cohen AF, Land G, et al. The pharmacokinetics of lamotrigine (BW430C) in healthy subjects with unconjugated hyperbilirubinaemia (Gilbert's Syndrome). Br J Clin Pharmacol 1989; 28:117-20.
9. Cociglio M, Arlic R, Bouvier O. Performance analysis of a reversed-phase liquid Chromatographic assay of lamotrigine in plasma using solvent-demixing extraction. J Chromatogr 1991; 572:269-76.
10. Sinz MW, Remmel RP. Analysis of lamotrigine and lamotrigine 2-N-glucuronide in guinea pig blood and urine by reserved-phase ion-pairing liquid chromatography. J Chromatogr 1991;571:217-30.
11. Fazio A, Artesi C, Russo M, et al. A liquid Chromatographic assay using a high-speed column for the determination of lamotrigine, a new antiepileptic drug, in human plasma. Ther Drug Monit 1992; 14:509-12.
12. Ramachandran S, Underhill S, Jones SR. Measurement of lamotrigine under conditions measuring phenobarbitone, phenytoin, and carbamazepine using reversed-phase high-performance liquid chromatography at dual wavelengths. Ther Drug Monit 1994;16: 75-82.
13. Fraser AD, MacNeil W, Isner AF, et al. Lamotrigine analysis in serum by high-performance liquid chromatography. Ther Drug Monit 1995;17:174-8.
14. Law B, Gill R, Moffat AC. High-performance liquid chromatography retention data for 84 basic drugs of forensic interest on a silica column using an aqueous methanol eluent. J Chromatogr 1984;301:165-72.
15. Cohen AF, Land GS, Breimer DD, et al. Lamotrigine, a new anticonvulsant: pharmacokinetics in normal humans. Clin Pharmacol Ther 1987;42:535-41.
16. Schlumberger E, Chavez F, Palacios L, et al. Lamotrigine in treatment of 120 children with epilepsy. Epilepsia 1994;35:359-67.
17. Eriksson A-S, Hoppu K, Nergardh A, et al. Pharmacokinetic interactions between lamotrigine and other antiepileptic drugs in children with intractable epilepsy. Epilepsia 1996;37:769-73.
18. Vauzelle-Kervroedan F, Rey E, Cieuta C, et al. Influence of concurrent antiepileptic medication on the pharmacokinetics of lamotrigine as add-on therapy in epileptic children. Br J Clin Pharmacol 1996;41:325-30.
19. Peck AW. Clinical pharmacology of lamotrigine. Epilepsia 1991; 32(suppl 21):S9-12.
20. Kilpatrick ES, Forrest G, Brodie MJ. Concentration-effect and concentration-toxicity relations with lamotrigine: a prospective study. Epilepsia 1996;37:534-38.